Table 1 Clinical characteristics of study patients
From: Tryptase as a marker of severity of aortic valve stenosis
| Sex/age, years | MACE-patients | Non-MACE patients | |||
|---|---|---|---|---|---|
| M/85 | F/58 | F/53 | F/72 | F/77 | |
| Clinical history | |||||
| Hypertension | Yes | Yes | Yes | Yes | Yes |
| Hypercolesterolemia | No | Yes | No | Yes | Yes |
| Currently smoking | Yes | No | No | No | No |
| Diabetes mellitus | No | Yes | No | No | No |
| Obesity | No | No | No | No | Yes |
| COPD | Yes | No | No | No | No |
| Left ventricle ejection fraction during index hospitalization | |||||
| Ejection fraction (%) | 30 | 58 | 56 | 40 | 60 |
| Mean transvalvular gradient (mmHg) | 70 | 75 | 70 | 65 | 65 |
| Diagnostic findings | |||||
| Tryptase, ng/ml | 10.9 | 11.7 | 9.32 | 5.69 | 5.58 |
| CRP, mg/dl | 3.2 | 0.8 | 0.2 | 0.3 | 1.1 |
| hsTnT, ng/l | 49.5 | 8.0 | 7.9 | 40 | 7.2 |
| Serum triglycerides, mg/dl | 117 | 189 | 150 | 176 | 68 |
| HDL cholesterol, mg/dl | 32 | 40 | 38 | 37 | 72 |
| LDL cholesterol, mg/dl | 90 | 97 | 100 | 116 | 89 |
| Plasma glucose, mg/dl | 119 | 181 | 104 | 87 | 114 |
| Major cardiovascular events | Sudden death | STEACS | STEACS | None | None |